Detalhe da pesquisa
1.
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Reduced Ejection Fraction.
Circulation
; 146(18): 1411-1414, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36029463
2.
Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial.
Cancer Prev Res (Phila)
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701435
3.
Effects of IL-1ß inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial.
Blood Adv
; 7(24): 7471-7484, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37934948
4.
Clinical characteristics of heart failure with reduced ejection fraction patients with rare pathogenic variants in dilated cardiomyopathy-associated genes: A subgroup analysis of the PARADIGM-HF trial.
Eur J Heart Fail
; 25(8): 1256-1266, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37191081
5.
TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial.
JAMA Cardiol
; 7(5): 521-528, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385050
6.
The ALS Nutrition/NIPPV Study: design, feasibility, and initial results.
Amyotroph Lateral Scler
; 12(1): 17-25, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21271789
7.
Coronary Artery Disease Polygenic Risk Score Identifies Patients at Higher Risk for Recurrent Cardiovascular Events in the CANTOS Trial.
Circ Genom Precis Med
; 14(6): e003440, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34663088